During the past decade, DaVita Central Orlando Dialysis conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "DaVita Central Orlando Dialysis" are "Pruritus" (2 trials) and "Uremic Pruritus" (2 trials). Many other conditions were trialed in "DaVita Central Orlando Dialysis" in a lesser frequency.

Most popular intervention types in "DaVita Central Orlando Dialysis" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo tablets BID" (1 trials), "nalbuphine HCl ER" (1 trials), "nalbuphine HCl ER tablets 120mg BID" (1 trials) and "nalbuphine HCl ER tablets 60 mg BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "DaVita Central Orlando Dialysis" are 2 trials for "All" genders.

Currently, there are NaN active trials in "DaVita Central Orlando Dialysis". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in DaVita Central Orlando Dialysis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DaVita Central Orlando Dialysis, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".